JAMA Neurology [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
===== JAMA Neurology =====

_JAMA Neurology_ is one of the most prestigious journals in clinical neurology, with a recent impact factor around 20–21, placing it among the global top three in the field. However, its status brings strengths and limitations that should be critically evaluated.

==== 🟢 Strengths ====
  * **High visibility**: The elevated impact factor ensures broad dissemination among neurologists and neuroscientists.
  * **Editorial rigor**: Peer review is fast and detailed (average 3–4 weeks according to SciRev).
  * **Efficient publishing**: Articles are often published online ahead of print, speeding dissemination.
  * **Author engagement**: Includes author interviews, podcasts, and media visibility.
  * **Focus on cutting-edge topics**: Regular publication of high-impact reviews, consensus statements, and original research.

==== 🔴 Limitations ====
  * **Citation-driven bias**: As with many high-IF journals, editorial decisions may be shaped by citation potential.
  * **Limited methodological diversity**: Replication studies, negative results, and regional data may be underrepresented.
  * **Industry influence risks**: Potential conflicts of interest from funding sources require critical appraisal, despite formal disclosure policies.
  * **Impact factor inflation practices**: The journal may (as many do) prioritize citable items like reviews, potentially distorting publication balance.

==== 🧭 Summary Judgment ====
| Aspect                 | Assessment |
|------------------------|------------|
| Scientific Rigor       | High       |
| Visibility & Prestige  | Very High  |
| Editorial Transparency | Moderate   |
| Methodological Breadth | Limited    |

==== 📝 Recommendation ====
For authors: Target JAMA Neurology if your work is novel, broadly relevant, and of high methodological quality.  
For readers: Critically evaluate articles, especially industry-funded studies or those with extraordinary claims. Look beyond the impact factor—rigor and reproducibility matter more than prestige.